Mabwell - About the company
Mabwell is a public company based in Pudong (China), founded in 2017 by Datao Liu. It operates as a R & D company focused on manufacturing of pharmaceutical products for multiple therapeutic products. Mabwell has raised $278M in funding from Shiyu.
Company Details
- Website
- mabwell.com
- Email ID
- *****@mabwell.com
- Phone Number
- +86 **********
Mabwell's IPO details
Mabwell got listed on Jan 21, 2022.
Click here to take a look at Mabwell's IPO in detail
Sign up to download Mabwell's company profile
Mabwell's funding and investors
Mabwell has raised a total funding of $278M over 2 rounds. Its first funding round was on Nov 2019. Its latest funding round was a Series A round on Apr 28, 2020 for $*****. 9 investors participated in its latest round. Mabwell has 12 institutional investors.
Here is the list of recent funding rounds of Mabwell:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 28, 2020 | 4421238 | Series A | 8313152 | 7072602 | 6001579 | 6644629 |
Nov 2019 | 2668673 | Seed | 3744286 | 9841047 | 7357036 | 4960300 |
Access funding benchmarks and valuations. Sign up today!View details of Mabwell's funding rounds and investors
Mabwell's founders and board of directors
Founder? Claim ProfileHere are the details of Mabwell's key team members:
- Datao Liu: Co-Founder of Mabwell.
- Xin Du: CEO of Mabwell. Contact Info: 1 email address
View details of Mabwell's Founder profiles and Board Members
Mabwell's employee count trend
Mabwell has 127 employees as of Aug 26. Here is Mabwell's employee count trend over the years:
Uncover Mabwell's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mabwell's Investments and acquisitions
Mabwell has made no investments or acquisitions yet.
Reports related to Mabwell
Here is the latest report on Mabwell's sector:
News related to Mabwell
Filter this listMedia has covered Mabwell for a total of 20 events in the last 1 year, 7 of them have been about company updates and 1 about partnerships.
•
Mabwell Secures Brazilian GMP Certification for Denosumab BiosimilarsPR Newswire•Aug 10, 2026•Mabwell
•
Mabwell Wins NMPA Nod to Test Novel Autoimmune Antibody 9MW5211 in VitiligoTipRanks•Jul 15, 2026•Mabwell
•
Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel DiseasePR Newswire•Jun 05, 2026•Mabwell
•
Mabwell to Present Clinical Data on 9MW2821 at 2026 ASCO Annual MeetingPR Newswire•May 22, 2026•Mabwell
•
•
World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial ApplicationPR Newswire•May 08, 2026•Mabwell
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Mabwell
Explore our recently published companies
- Alexander Construction - Houston based, Unfunded company
- Rnbcorp - Unfunded company
- SeekAdvantage - Unfunded company
- Ice Guy Consulting - Unfunded company
- Ly Advisory - Unfunded company
- Leo-Ag - Unfunded company
